Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-8 of 8 for your search:
Drug:
raloxifene
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Effect of Bazedoxifene, Raloxifene, and Placebo on Breast Density
Phase:
Phase IV
Type:
Diagnostic, Treatment
Status:
Completed
Age:
18 to 63
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
3068A1-400
, NCT00418236
2.
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Phase:
Phase III
Type:
Prevention
Status:
Closed
Age:
35 and over
Sponsor:
NCI, Other
Protocol IDs:
NSABP P-2
, CDR0000067081, NCT00003906
3.
Phase II Study of Raloxifene as a Chemopreventive Agent for Premenopausal Women at High Risk for Developing Invasive Breast Cancer
Phase:
Phase II
Type:
Prevention
Status:
Completed
Age:
23 to 47
Sponsor:
NCI
Protocol IDs:
NCI-98-C-0123
, MB-402, NCT00019500
4.
Phase II Randomized Study of Exemestane and Raloxifene in Postmenopausal Women With a History of Stage 0 (Ductal Carcinoma in Situ), I, II, or III Breast Cancer Who Have No Clinical Evidence of Disease
Phase:
Phase II
Type:
Prevention, Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MSKCC-99017
, NCI-G99-1662, NCT00004247
5.
Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI, Other
Protocol IDs:
CDR0000067595
, NU-98G1, NCI-G00-1710, NCT00004915
6.
Pilot Randomized Study of Raloxifene and Goserelin Versus No Medical Intervention in Women at High Genetic Risk for Developing Breast Cancer
Phase:
No phase specified
Type:
Prevention
Status:
Completed
Age:
30 to 45
Sponsor:
Other
Protocol IDs:
NCRI-IBIS-RAZOR
, EU-20053, UKCCCR-IBIS-RAZOR, ISRCTN17775670, NCT00031850
7.
Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer
Phase:
No phase specified
Type:
Supportive care
Status:
Closed
Age:
Any age
Sponsor:
NCI, Other
Protocol IDs:
CDR0000069229
, OHSU-6312, NCI-H02-0086, NCT00031811
8.
Cognitive Aging - STAR
Phase:
No phase specified
Type:
Natural history/Epidemiology, Supportive care
Status:
Completed
Age:
65 and over
Sponsor:
NCI, Other
Protocol IDs:
Cognitive Aging - STAR
, CoStar, NCT00571857
Select All on Page
Help with Results
